Jin Yang Pharmaceutical Co. Ltd (007370) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.53 Billion ≈ $3.07 Million USD) by net assets (₩159.98 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jin Yang Pharmaceutical Co. Ltd (007370) total market value for the company's overall valuation and market capitalisation.

Jin Yang Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jin Yang Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Explore Jin Yang Pharmaceutical Co. Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Display Tech Co. Ltd KQ:066670	-0.030x
Dancomech Holdings Bhd KLSE:5276	0.019x
Hung Chou Fiber Ind Co Ltd TW:1413	0.023x
OKYO PHARMA LTD SP.ADR/65 F:OK10	N/A
Asia Metal Public Company Limited BK:AMC	0.077x
Memscap Regpt PA:MEMS	0.026x
Freelancer Ltd AU:FLN	-0.023x
JR HOLDING SA BC ZY -10 F:8JA	0.000x

Annual Cash Flow Conversion Efficiency for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025. View Jin Yang Pharmaceutical Co. Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.86 Billion ≈ $108.33 Million	₩1.46 Billion ≈ $992.80K	0.009x	-91.41%
2024-12-31	₩119.88 Billion ≈ $81.24 Million	₩12.79 Billion ≈ $8.67 Million	0.107x	+12.02%
2023-12-31	₩89.58 Billion ≈ $60.71 Million	₩8.53 Billion ≈ $5.78 Million	0.095x	-0.78%
2022-12-31	₩77.58 Billion ≈ $52.57 Million	₩7.45 Billion ≈ $5.05 Million	0.096x	+218.24%
2021-12-31	₩65.32 Billion ≈ $44.26 Million	₩1.97 Billion ≈ $1.34 Million	0.030x	-77.63%
2020-12-31	₩46.31 Billion ≈ $31.38 Million	₩6.24 Billion ≈ $4.23 Million	0.135x	-18.33%
2019-12-31	₩43.67 Billion ≈ $29.59 Million	₩7.21 Billion ≈ $4.89 Million	0.165x	+555.78%
2018-12-31	₩42.05 Billion ≈ $28.50 Million	₩1.06 Billion ≈ $717.38K	0.025x	+208.08%
2017-12-31	₩42.38 Billion ≈ $28.72 Million	₩-987.16 Million ≈ $-668.99K	-0.023x	-8399.26%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-13.47 Million ≈ $-9.13K	0.000x	+99.41%
2015-12-31	₩59.18 Billion ≈ $40.10 Million	₩-2.76 Billion ≈ $-1.87 Million	-0.047x	+7.06%
2014-12-31	₩61.48 Billion ≈ $41.66 Million	₩-3.08 Billion ≈ $-2.09 Million	-0.050x	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$38.32 Million

₩56.54 Billion KRW

Market Cap Rank

#22970 Global

#1523 in Korea

Share Price

₩4000.00

Change (1 day)

+0.63%

52-Week Range

₩3440.00 - ₩5980.00

All Time High

₩9262.22